All In Biotech

Drug Trial Radar · NCT07673029

A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer

A Phase III, Multicenter, Open-label, Randomized Controlled Study Comparing GQ1005 and Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer Previously Treated With Trastuzumab and a Taxane

Last checked: Nov 19, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 228 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

228

Planned (sponsor's estimate)

Start

Jan 10, 2025

Primary completion

Jan 9, 2027

Study completion Jan 9, 2028

Sponsor

Sponsor type
Industry
First posted
Jun 29, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to compare efficacy and safety of GQ1005 versus T-DM1 in HER2-positive, unresectable and/or metastatic breast cancer patients previously treated with trastuzumab and taxane.

Conditions

  • HER2-positive Breast Cancer

Interventions

  • GQ1005Drug

    Administered I.V.

  • T-DM1Drug

    Administered I.V.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression Free Survival (PFS) by Blinded Independent Central Review (BICR) assessment per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1)Time frame: Up to approximately 24 months

Locations

70 sites in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Bengbu Medical University

    Bengbu, Anhui, China · Recruiting

  • The Affiliated Fuyang Hospital of Anhui Medical University

    Fuyang, Anhui, China · Recruiting

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, Anhui, China · Recruiting

  • Anhui Cancer Hospital

    Hefei, Anhui, China · Recruiting

  • The Fifth Medical Center of the Chinese People's Liberation Army General Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Chongqing University Cancer Hospital

    Chongqing, Chongqing Municipality, China · Recruiting

  • Fujian Cancer Hospital

    Fuzhou, Fujian, China · Recruiting

  • The Second Affiliated Hospital of Fujian Medical University

    Quanzhou, Fujian, China · Recruiting

  • Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong, China · Recruiting

  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, China · Recruiting

  • Meizhou People's Hospital

    Meizhou, Guangdong, China · Recruiting

  • Shantou Central Hospital

    Shantou, Guangdong, China · Recruiting

  • Guangxi Medical University Cancer Hospital

    Nanning, Guangxi, China · Recruiting

  • Guizhou Provincial People's Hospital

    Guiyang, Guizhou, China · Recruiting

  • Guizhou Medical University Cancer Hospital

    Guiyang, Guizhou, China · Recruiting

  • The Affiliated Hospital of Hebei University

    Baoding, Hebei, China · Recruiting

  • The Affiliated Hospital of Hebei University of Engineering

    Handan, Hebei, China · Recruiting

  • The Fourth Hospital of Hebei Medical University

    Shijiazhuang, Hebei, China · Recruiting

  • Xingtai People's Hospital

    Xingtai, Hebei, China · Recruiting

  • Harbin Medical University Cancer Hospital

    Harbin, Heilongjiang, China · Recruiting

  • Anyang Cancer Hospital

    Anyang, Henan, China · Recruiting

  • Luoyang Central Hospital

    Luoyang, Henan, China · Recruiting

  • The First Affiliated Hospital of Henan University of Science and Technology

    Luoyang, Henan, China · Recruiting

  • The First Affiliated Hospital of Henan Medical University

    Xinxiang, Henan, China · Recruiting

  • Xuchang Central Hospital

    Xuchang, Henan, China · Recruiting

  • Henan Cancer Hospital

    Zhengzhou, Henan, China · Recruiting

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, China · Recruiting

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China · Recruiting

  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China · Recruiting

  • Renmin Hospital of Wuhan University

    Wuhan, Hubei, China · Recruiting

  • Zhongnan Hospital of Wuhan University

    Wuhan, Hubei, China · Recruiting

  • Hubei Cancer Hospital

    Wuhan, Hubei, China · Recruiting

  • Hunan Cancer Hospital

    Changsha, Hunan, China · Recruiting

  • Yongzhou Central Hospital

    Yongzhou, Hunan, China · Recruiting

  • Xuzhou Central Hospital

    Xuzhou, Jiangsu, China · Recruiting

  • Ganzhou Cancer Hospital

    Ganzhou, Jiangxi, China · Recruiting

  • Nanchang People's Hospital

    Nanchang, Jiangxi, China · Recruiting

  • The First Hospital of Jilin University

    Changchun, Jilin, China · Recruiting

  • The Second Affiliated Hospital of Dalian Medical University

    Dalian, Liaoning, China · Recruiting

  • The First Affiliated Hospital of Jinzhou Medical University

    Jinzhou, Liaoning, China · Recruiting

Showing 40 of 70 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.